
According to the company’s official statement, the rebrand aims to position ETHZilla as a leading Ethereum treasury firm, backed by major institutional and crypto investors.
ETHZilla Corporation (NASDAQ: ETHZ), formerly 180 Life Sciences, has rebranded and now trades under ETHZ and ETHZW on the Nasdaq Capital Market. The firm holds 94,675 ETH valued at over $405 million, ranking fifth among public companies by Ethereum holdings. The rebrand follows $565 million in fundraising via private placements and convertible note offerings, attracting over 60 institutional and crypto-focused investors, including Harbour Island, Electric Capital, Polychain Capital, and GSR. ETHZilla has appointed Electric Capital as external asset manager to run an on-chain yield program aiming to outperform conventional ETH staking returns, while continuing operations in iGaming and monetizing its biotech IP portfolio.